PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
February 27 2025 - 7:00AM
PMGC Holdings Inc. (the “Company” or “PMGC,” “our,” or
“we”) (Nasdaq: ELAB), a diversified holding company, is
proud to announce its annual sponsorship of TCA Venture Group’s
(“TCA”) Orange County network for 2025. As a Southern California
Network Sponsor, PMGC is actively pursuing investments and M&A
opportunities to strengthen its portfolio while fostering local
business growth and expanding its market presence.
TCA Venture Group (formerly known as Tech Coast Angels) is one
of the largest and most active angel investor networks in the
United States. With a history spanning over 25 years, TCA has been
instrumental in funding early-stage and seed-stage companies across
all innovation-driven industries. Since its founding in 1997, TCA
members have invested over $300 million in more than 525 companies,
attracting an additional $2.2 billion in follow-on investments,
primarily from venture capital firms.
“We are excited to join forces with TCA Venture Group as a key
sponsor,” said Graydon Bensler, CFA, Chief Executive Officer of
PMGC. “This sponsorship aligns perfectly with our mission to
identify and support high-potential companies, providing both
capital and operational expertise to drive long-term growth. TCA’s
vast network of investors, entrepreneurs, and industry experts will
enhance our ability to expand our portfolio and execute our
acquisition strategy while directly contributing to the thriving
Southern California business ecosystem.”
PMGC currently manages and operates a diverse portfolio of three
wholly owned subsidiaries:
- NorthStrive
Biosciences Inc. – A biopharmaceutical company focusing on
the development and acquisition of cutting-edge aesthetic
medicines. Our lead asset, EL-22, is leveraging an engineered
probiotic approach to address obesity’s pressing issue of
preserving muscle while on weight loss treatments, including GLP-1
receptor agonists. For more information, please visit
www.northstrivebio.com.
- PMGC
Research Inc. – A research and development subsidiary,
currently utilizing Canadian research grants and partnering with
leading Canadian universities to accelerate scientific discovery
and transform cutting-edge technologies into commercially viable
products.
- PMGC Capital
LLC. – A multi-strategy investment firm focused on direct
investments, strategic lending, and acquiring undervalued companies
and assets across diverse markets. The company’s mission is to
identify and seize high-potential opportunities, delivering
sustainable growth and maximizing returns on capital.
Through this sponsorship, PMGC will gain valuable exposure
through TCA’s national network, engage with over 400 seasoned
investors, business leaders, and industry professionals. TCA
members, consisting of experienced C-level executives,
entrepreneurs, venture capitalists, and other professionals, not
only invest in early-stage companies but also provide hands-on
mentorship, board representation, and strategic partnerships. TCA
is one of the largest and most active angel investor groups
nationally, consistently ranking in the top three for deals funded,
amounts invested, and membership size. The HALO Report recently
ranked TCA as # 2 U.S. angel investment network for funded deals,
and CB Insights, a market intelligence platform, has recognized TCA
as the top-ranked angel group in terms of network centrality.
By aligning with TCA, PMGC strengthens its commitment to
fostering entrepreneurial success and supporting innovative
businesses. The Company believes this collaboration will open doors
to new investment opportunities and further enhance PMGC’s position
as a leading player in the investment and M&A landscape.
About PMGC Holdings Inc.PMGC Holdings Inc. is a
diversified holding company that manages and grows its portfolio
through strategic acquisitions, investments, and development across
various industries. Currently, our portfolio consists of three
wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC
Research Inc., and PMGC Capital LLC. We are committed to exploring
opportunities in multiple sectors to maximize growth and value. For
more information, please visit https://www.pmgcholdings.com.
About TCA Venture GroupTCA Venture Group is one
of the largest and most active angel investor networks in the
nation, and a leading source of funding for seed-stage and
early-stage companies across all innovation industries in Southern
California. TCA members are accredited investors who individually
invest in startup companies. Companies go through well-structured,
transparent, and time efficient screening and due diligence. As
founders and executive-level business leaders, TCA members provide
companies with more than just capital; they also contribute
counsel, mentoring and access to an extensive network of investors,
customers, strategic partners and management. TCA is a catalyst in
the growth of the thriving Southern California entrepreneurial
ecosystem of innovation. Since its founding in 1997, TCA has
invested over $218 million in more than 380 companies and has
helped attract more than $1.66 billion in additional
capital/follow-on rounds, mostly from venture capital firms.
Learn more
at www.tcaventuregroup.com.
Forward-Looking StatementsStatements contained
in this press release regarding matters that are not historical
facts are “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995, as amended. Words
such as “believes,” “expects,” “plans,” “potential,” “would” and
“future” or similar expressions such as “look forward” are intended
to identify forward-looking statements. Forward-looking statements
are made as of the date of this press release and are neither
historical facts nor assurances of future performance. Instead,
they are based only on our current beliefs, expectations and
assumptions regarding the future of our business, future plans and
strategies, projections, anticipated events and trends, the
economy, activities of regulators and future regulations and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of
which are outside of our control. Although the Company believes
that the expectations expressed in these forward-looking statements
are reasonable, it cannot assure you that such expectations will
turn out to be correct, and the Company cautions investors that
actual results may differ materially from the anticipated results.
Therefore, you should not rely on any of these forward-looking
statements. These and other risks are described more fully in PMGC
Holdings’ filings with the United States Securities and Exchange
Commission (“SEC”), including the “Risk Factors” section of the
Company’s Annual Report on Form 10-K for the year ended December
31, 2023, filed with the SEC on March 29, 2024, and its other
documents subsequently filed with or furnished to the SEC.
Investors and security holders are urged to read these documents
free of charge on the SEC’s web site at www.sec.gov. All
forward-looking statements contained in this press release speak
only as of the date on which they were made. Except to the extent
required by law, the Company undertakes no obligation to update
such statements to reflect events that occur or circumstances that
exist after the date on which they were made.
IR Contact:IR@pmgcholdings.com
PMGC (NASDAQ:ELAB)
Historical Stock Chart
From Feb 2025 to Mar 2025
PMGC (NASDAQ:ELAB)
Historical Stock Chart
From Mar 2024 to Mar 2025